For Biotech Investors: 5 Orphan Drugs And Their Parent Companies
By Brian L. Wilson : This year, one of many trends in the world of biotech investing is the increasing popularity of orphan drugs on Wall Street. An orphan drug is a special designation that is given to drugs that are intended to treat very rare diseases (in the United States this means less than ...
Read the rest of this article on Healthcare Sector and Stocks Analysis from Seeking Alpha
Related Videos
-
Will 'Knockout' Mice Make a Knockout Stock?After a strong runup from our recommendation, is it time to take money off the table in Lexicon Pharmaceuticals ?
-
Freeman: The Next Growth OpportunitiesVeteran growth manager Richie Freeman on the bright prospects for biotechnology , LED lighting, flash memory, and the outlook for energy in light of the Gulf oil spill.
-
No Sign of Slowdown in Biotech M&AHigh levels of merger and acquisition activity will be the big theme of year for biotech , says Morningstar's Lauren Migliore.
-
Top Biotech Acquisition Candidates2011 was a relatively light year for biotech M&A, but it looks like activity is picking up in 2012.